Accidente cerebrovascular: un manto oscuro en pediatría
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Rev. bol. ped.
Abstract
El actual arsenal de exámenes de laboratorio y de neuroimagen permite afirmar que las enfermedades cerebrovasculares (ECV) en pediatría, desde la etapa prenatal hasta la adolescencia, ya no constituyen una patología inusual, ni idiopática, ni tampoco benigna. Asimismo, los actuales procedimientos en las terapias intensivas, el uso de fármacos neuroprotectores y antiagregantes plaquetarios o las nuevas técnicas de neurorradiología intervencionista, también han modificado favorablemente la morbimortalidad de estos pacientes. A pesar del impacto de las ECV en la salud pública de los niños, todavía no existen guías o protocolos consensuados para tratar las diversas patologías vasculares en estos grupos. Se presenta una sucinta revisión bibliográfica respecto a su presentación clínica, actual abordaje diagnóstico y terapéutico.
The current arsenal of laboratory tests and neuroimaging suggests that pediatric cerebrovascular disease, from prenatal through adolescence, are not an unusual, or idiopathic disease, nor benign pathology. Moreover, the current procedures in intensive care, the use of neuroprotective therapy or antiplatelet drugs, also have changed favorably the morbidity and mortality of these patients. Despite the impact of cerebrovascular diseases on children, guidelines or consensus for treating them in this age group have not been developed yet. In addition, this study encouraged us to make a brief literature review regarding clinical presentation, diagnostic and therapeutic approach.
The current arsenal of laboratory tests and neuroimaging suggests that pediatric cerebrovascular disease, from prenatal through adolescence, are not an unusual, or idiopathic disease, nor benign pathology. Moreover, the current procedures in intensive care, the use of neuroprotective therapy or antiplatelet drugs, also have changed favorably the morbidity and mortality of these patients. Despite the impact of cerebrovascular diseases on children, guidelines or consensus for treating them in this age group have not been developed yet. In addition, this study encouraged us to make a brief literature review regarding clinical presentation, diagnostic and therapeutic approach.
Description
Vol. 53, No. 3